| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/31/2001 | US6267982 Estradiol dissolved in (meth)acrylate copolymer by drying and present in at least three times saturation solubility concentration measured at 95% relative air humidity, enclosed in moisture-tight package with low humidity air |
| 07/31/2001 | CA2218372C Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 07/31/2001 | CA2118119C Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 07/26/2001 | WO2001053531A2 Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells |
| 07/26/2001 | WO2001053353A2 Recombinant antibodies to human interkleukin-1 beta |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001053297A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053295A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin |
| 07/26/2001 | WO2001053285A1 Food product and process |
| 07/26/2001 | WO2001053282A1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/26/2001 | WO2001053280A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 07/26/2001 | WO2001053279A1 Urea compounds as inhibitors for vla-4 |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053261A1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 07/26/2001 | WO2001053254A1 Calcilytic compounds |
| 07/26/2001 | WO2001052892A2 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | WO2001052859A1 Pharmaceutical parenteral composition containing a biphosphonate |
| 07/26/2001 | WO2001052847A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | WO2001052845A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | WO2001052829A2 Statin-type bone growth stimulators |
| 07/26/2001 | WO2001052825A2 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001046180A8 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001014886A3 Inhibitors of binding between proteins and macromolecular ligands |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | US20010009921 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/26/2001 | US20010009920 Combination therapy for osteoporosis |
| 07/26/2001 | DE10002510A1 New phenylamidine compounds are useful for the treatment of thrombosis, cerebrovascular disorders, heart infarction, arteriosclerosis, osteoporosis, tumor metastasis, shock and diabetes |
| 07/26/2001 | DE10002509A1 New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders |
| 07/26/2001 | CA2673615A1 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production |
| 07/26/2001 | CA2397833A1 Novel haptotactic peptides |
| 07/26/2001 | CA2397802A1 Calcilytic compounds |
| 07/26/2001 | CA2397774A1 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | CA2397686A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | CA2397665A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | CA2397659A1 Statin-type bone growth stimulators |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397627A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | CA2397565A1 Food product and process |
| 07/26/2001 | CA2397533A1 Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for preparation thereof |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2396212A1 Recombinant antibodies to human interleukin-1 beta |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2332214A1 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118332A1 A composition for treating degenerative joint diseases |
| 07/25/2001 | EP1118328A1 Insertion stabilizers for implants |
| 07/25/2001 | EP1118323A2 Method of reducing morbidity and the risk of mortality |
| 07/25/2001 | EP1117805A2 Modified tgf-beta superfamily proteins |
| 07/25/2001 | EP1117795A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117772A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 07/25/2001 | EP1117764A1 Primate embryonic stem cells with compatible histocompatibility genes |
| 07/25/2001 | EP1117689A1 Bone morphogenetic protein antagonists based on the mature protein |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117658A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 07/25/2001 | EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 07/25/2001 | EP1117655A1 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders |
| 07/25/2001 | EP1117653A1 Chemical compounds |
| 07/25/2001 | EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/25/2001 | EP1117443A1 Peptide-based carrier devices for stellate cells |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117427A2 USE OF $i(PEX) IN THE TREATMENT OF METABOLIC BONE DISEASES |
| 07/25/2001 | EP1117422A1 Repair of larynx, trachea, and other fibrocartilaginous tissues |
| 07/25/2001 | EP1117418A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117416A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117412A1 Compositions containing diphosphonic acids |
| 07/25/2001 | EP1117411A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 07/25/2001 | EP1117410A1 Use of bisphosphonic acid derivatives for preparing a medicine for treating lameness |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117296A1 Combination of bisphosphonate and tetracycline |
| 07/25/2001 | EP0788362B1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305480A Pyrolo [2,3-d] pyrimidine compounds |
| 07/25/2001 | CN1305479A Pyrrolo [2,3-d] pyrmidine compounds |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/25/2001 | CN1305378A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal fragility |
| 07/25/2001 | CN1305373A Therapeutic combinations comprising selective estrofen receptor modulator and parathyroid hormone |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/25/2001 | CN1304763A Medicine for treating scleroderma and its preparing process |
| 07/25/2001 | CN1304760A Plaster for treating ostalgia and its preparing process |
| 07/25/2001 | CN1304752A Clematis capsule and its preparing process |
| 07/25/2001 | CN1304747A Compound capsule for treating hyperosteogeny and rheumatism and its preparing process |
| 07/25/2001 | CN1304746A Medicine for treating hyperosteogeny and its preparing process |
| 07/25/2001 | CN1304745A Medicine for treating hyperosteogeny |
| 07/25/2001 | CN1304743A Medicine for treating injury |
| 07/25/2001 | CN1304742A Ointment for treating bone fracture and injury |
| 07/25/2001 | CN1304741A Lumbago plaster |
| 07/25/2001 | CN1304740A Hyperosteogeny plaster |
| 07/25/2001 | CN1304739A Plaster for treating periomethritis |